Cargando…
Laboratory monitoring to reduce adverse drug-related events: a mixed methods study
BACKGROUND: Therapy with angiotensinconverting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) requires laboratory monitoring to avoid hyperkalemia and acute kidney failure. OBJECTIVE: To assess the frequency of recommended annual serum potassium and creatinine monitoring and dete...
Autores principales: | Harrison, Teresa N, Reynolds, Kristi, Hahn, Erin E, Munoz-Plaza, Corrine E, Yi, David K, Fischer, Heidi, Luong, Tiffany Q, Sim, John J, Brettler, Jeffrey, Handler, Joel, Mittman, Brian S, Singh, Hardeep, Kanter, Michael H, Danforth, Kim N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398702/ https://www.ncbi.nlm.nih.gov/pubmed/34949121 http://dx.doi.org/10.18553/jmcp.2022.28.1.16 |
Ejemplares similares
-
Risk of hospitalization and mortality associated with uncontrolled blood pressure in patients with hypertension and COVID-19
por: An, Jaejin, et al.
Publicado: (2021) -
Long‐Term Medication Adherence Trajectories to Direct Oral Anticoagulants and Clinical Outcomes in Patients With Atrial Fibrillation
por: An, Jaejin, et al.
Publicado: (2021) -
Angiotensin‐Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID‐19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System
por: An, Jaejin, et al.
Publicado: (2021) -
COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system
por: An, Jaejin, et al.
Publicado: (2021) -
Electronic Clinical Surveillance to Improve Outpatient Care: Diverse Applications within an Integrated Delivery System
por: Danforth, Kim N., et al.
Publicado: (2014)